Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
5,32 USD | +1,92% | -3,10% | -47,48% |
Métier
Nombre d'employés: 265
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Genome Editing Technology
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01/06/22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 17/05/23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 24/07/23 |
Mei Baisong
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/07/22 |
Chi Li
LAW | General Counsel | - | 14/06/21 |
Linea Aspesi
HRO | Human Resources Officer | - | 01/02/23 |
Charlene Stern
LAW | General Counsel | - | 01/01/13 |
Kate X. Zhang
PRN | Corporate Officer/Principal | - | 01/10/18 |
Caren Deardorf
PRN | Corporate Officer/Principal | 59 | 26/09/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 03/09/21 |
David Scadden
BRD | Director/Board Member | 71 | 06/02/19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 28/07/16 |
Andrew Hirsch
BRD | Director/Board Member | 53 | 30/05/17 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 16/02/18 |
Elliott Levy
BRD | Director/Board Member | 64 | 11/04/23 |
Director/Board Member | 65 | 26/10/21 | |
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01/06/22 |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 17/12/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 82 234 710 | 81 969 942 ( 99,68 %) | 0 | 99,68 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-47,48% | 437 M | |
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |
- Bourse
- Actions
- Action EDIT
- Société Editas Medicine, Inc.